We found that downregulation of FTO or overexpression of METTL14 had similar effects on multiple aspects of esophageal cancer progression, including migration, invasion, proliferation, and tumorigenesis, which also suggested that FTO function could be restored by METTL14 in esophageal cancer. Here, FTO is linked to esophageal cancer.